Nashville, TN 的 直腸癌 臨床試驗
9 項針對 直腸癌 的研究正在 Nashville（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- Sarah Cannon Research Institue, Nashville
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
招募中1/2 期
- Tennessee Oncology, PLLC, Nashville
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
招募中1/2 期
- GSK Investigational Site, Nashville
ColoSeal™ ICD System Anastomotic Protection Pivotal Study
招募中
- Vanderbilt University Medical Center, Nashville
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
招募中3 期
- Vanderbilt University/Ingram Cancer Center, Nashville
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
招募中1/2 期
- Vanderbilt University Medical Center, Nashville
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
招募中2 期
- SCRI Oncology Partners, Nashville
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
招募中1/2 期
- Sarah Cannon Research Institute, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Nashville
其他城市的 直腸癌 試驗
- New York City, NY17 項研究
- Boston, MA12 項研究
- St. Louis, MO11 項研究
- Houston, TX11 項研究
- Columbus, OH10 項研究
- Los Angeles, CA10 項研究
- Tampa, FL9 項研究
- Seattle, WA9 項研究
- Salt Lake City, UT8 項研究
- Edison, NJ8 項研究
- Aurora, CO8 項研究
- Baldwin Park, CA8 項研究
Nashville 的其他研究
- 非小細胞肺癌97 項研究
- 乳癌80 項研究
- 轉移性癌症70 項研究
- 大腸直腸癌69 項研究
- 癌症（所有類型）65 項研究
- 卵巢癌49 項研究
- 前列腺癌43 項研究
- 肺癌40 項研究
- 頭頸部鱗狀細胞癌39 項研究
- 胰臟癌39 項研究
- 子宮內膜癌38 項研究
- 黑色素瘤33 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月7日。各研究自行設定資格標準；由研究團隊決定參與者資格。